We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+12.71%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$322M
Cap. Flow
+$229M
Cap. Flow %
16.07%
Top 10 Hldgs %
6.36%
Holding
2,241
New
645
Increased
572
Reduced
474
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$13.4M
2
NVDA icon
NVIDIA
NVDA
+$12.7M
3
MSFT icon
Microsoft
MSFT
+$11.3M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$8.44M
5
JPM icon
JPMorgan Chase
JPM
+$6.53M

Top Sells

Rank Stock Value
1
CSX icon
CSX Corp
CSX
+$4.12M
2
BX icon
Blackstone
BX
+$3.99M
3
KLG
WK Kellogg Co
KLG
+$3.21M
4
CALM icon
Cal-Maine
CALM
+$2.92M
5
FRO icon
Frontline
FRO
+$2.74M

Sector Composition

Rank Sector Weight
1 Technology 18.54%
2 Financials 15.47%
3 Healthcare 14.21%
4 Industrials 11.6%
5 Consumer Discretionary 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBYI icon
2051
Puma Biotechnology
PBYI
$413M
-99,394
Closed -$294K
PCOR icon
2052
Procore
PCOR
$8.47B
-3,657
Closed -$241K
PCRX icon
2053
Pacira BioSciences
PCRX
$1.02B
-10,973
Closed -$273K
PDFS icon
2054
PDF Solutions
PDFS
$1.92B
-26,171
Closed -$500K
PGRE
2055
DELISTED
Paramount Group
PGRE
-402,937
Closed -$1.73M
PHR icon
2056
Phreesia
PHR
$706M
-35,219
Closed -$900K
PII icon
2057
Polaris
PII
$3.99B
-7,444
Closed -$305K
PKW icon
2058
Invesco BuyBack Achievers ETF
PKW
$1.75B
-2,936
Closed -$331K
PLSE icon
2059
Pulse Biosciences
PLSE
$2.65B
-10,916
Closed -$176K
PLX icon
2060
Protalix BioTherapeutics
PLX
$197M
-209,292
Closed -$536K
PLYA
2061
DELISTED
Playa Hotels & Resorts
PLYA
-14,343
Closed -$191K
PM icon
2062
Philip Morris
PM
$293B
-1,859
Closed -$295K
PNR icon
2063
Pentair
PNR
$11.2B
-3,996
Closed -$350K
PPBI
2064
DELISTED
Pacific Premier Bancorp
PPBI
-18,505
Closed -$395K
PPG icon
2065
PPG Industries
PPG
$26B
-2,011
Closed -$220K
PR
2066
Permian Resources
PR
$17B
-133,771
Closed -$1.85M
PRDO icon
2067
Perdoceo Education
PRDO
$2.03B
-17,689
Closed -$445K
PRGO icon
2068
Perrigo
PRGO
$1.74B
-9,435
Closed -$265K
PRIM icon
2069
Primoris Services
PRIM
$4.35B
-15,322
Closed -$880K
PRME icon
2070
Prime Medicine
PRME
$533M
-153,273
Closed -$305K
PRQR icon
2071
ProQR Therapeutics
PRQR
$268M
-14,683
Closed -$20K
PRVA icon
2072
Privia Health
PRVA
$2.77B
-51,026
Closed -$1.15M
PSX icon
2073
Phillips 66
PSX
$82.4B
-4,295
Closed -$530K
PTC icon
2074
PTC
PTC
$16B
-5,713
Closed -$885K
PTGX icon
2075
Protagonist Therapeutics
PTGX
$9.4B
-11,963
Closed -$579K

Similar funds

GSA Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, GSA Capital Partners held 2,241 positions worth $1.43B, up 29% from $1.11B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

GSA Capital Partners deployed $229M of net new capital in Q2 2025, opening 645 new positions and adding to 572 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 16,625 shares worth $8.08M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was CSX Corp, an estimated $4.12M trimmed.

  • GSA Capital Partners's largest Q2 2025 buy was Berkshire Hathaway Class B: 16,625 shares worth $8.08M.
  • GSA Capital Partners added most to Apple in Q2 2025, an estimated $13.4M increase.
  • GSA Capital Partners's biggest Q2 2025 reduction was CSX Corp, cutting an estimated $4.12M.
  • GSA Capital Partners fully exited WK Kellogg Co in Q2 2025, selling an estimated $3.21M.
  • GSA Capital Partners's ten largest holdings make up 6.4% of its $1.43B portfolio in Q2 2025.
  • GSA Capital Partners opened 645 new positions and closed 546 in Q2 2025.
  • GSA Capital Partners's portfolio value rose 29% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.